Filana Therapeutics Inc (FLNA) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Filana Therapeutics Inc   (NASDAQ: FLNA)


Filana Therapeutics Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Filana Therapeutics Inc's ROI in the first quarter of 2026?
Filana Therapeutics Inc recorded a cumulative net loss of $-78 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -98.52%.

Within the Healthcare sector 664 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2026 quarter, so far to 4040, from total ROI ranking in the fourth quarter of 2025 at 4699.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM -50.05 % -34.52 % -21.11 % -4.29 % 15.02 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 68 75 82 92 132
Return On Investment (TTM) -98.52 % -95.81 % -94.02 % -91.9 % -45.98 %
FLNA's Overall Ranking # 4040 # 4699 # 4147 # 4176 # 3872
Seq. Investment Change TTM -16.72 % -15.8 % -15.86 % -15.34 % 9.17 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -78 -91 -106 -123 -73

FLNA Company Profile >> Back to FLNA Roi Comparisons >> See Annual FLNA Return On Investment



Return On Investment FLNA's Ranking
Within: No.
Industry # 301
Sector # 665
Overall # 4040

Return On Investment Statistics
High Average Low
70.27 %
-31.74 %
-101.51 %
(Dec 31 2013)   (Mar 31 2018)







Financial Statements
Filana Therapeutics Inc's I. Quarter Investments $ 68 Millions FLNA's Balance sheet
Filana Therapeutics Inc's I. Quarter Income $ -10 Millions Quarterly FLNA's Income Statement
FLNA's Income by Division See FLNA's Income by Division


FLNA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 75 146 137 228 254
Y / Y Investment Growth -48.88 % 6.05 % -39.65 % -10.41 % 175.06 %
Net Income in Millions -91 19 -97 -76 -32
Y / Y Net Income Growth - - - - -
Annual Return On Investment -122.08 % 13.34 % -70.72 % -33.47 % -12.74 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FLNA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FLNA's Competitors
Subscribers only: Roi for Filana Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for FLNA's Customers

Other Ratios
FLNA's Roa FLNA's Inventory Turnover Ratio FLNA's Growth Rates FLNA's Dividend Statistics
FLNA's Profitability Ratios FLNA's Asset Turnover Ratio FLNA's Dividend Growth
FLNA's Roe FLNA's Valuation Ratios FLNA's Financial Strength Ratios FLNA's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T17:42:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.